HNRNPA2B1 and cancer: In a recent study using immuno-deficient mice implanted with human tumor cell xenografts, apigenin appeared to induce transcriptome-wide reprogramming of cancer-associated alternative splicing in an RNA binding protein (hnRNPA2)-associated manner and induce switching of cancer-associated to non-cancer-associated alternative spliced isoforms (102).